Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Laryngoscope|December 30, 2022
T4b Sinonasal Squamous Cell Carcinoma: Surgery Plus Radiotherapy May Contribute to Prolonged SurvivalZekun Wang, Jianghu Zhang, Bining Yang, et al.
Cancer Medicine|January 26, 2022
Evaluation of the prevalence of metachronous second primary malignancies in hypopharyngeal carcinoma and their effect on outcomesXi Luo, Xiaodong Huang, Shaoyan Liu, et al.
Radiation Oncology (London, England)|January 22, 2022
Irradiation-induced nasopharyngeal necrosis (INN) in newly diagnosed nasopharyngeal carcinoma treated by intensity-modulated radiation therapy: clinical characteristics and the influence of treatment strategiesYi Xu, Yang Liu, Zekun Wang, et al.
The Laryngoscope|November 2, 2022
Synchronous Second Primary Cancers of Hypopharyngeal Carcinoma in the Image-Enhanced Endoscopy EraXi Luo, Xiaodong Huang, Shaoyan Liu, et al.
JAMA Network Open|February 22, 2022
Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal CarcinomaXi Luo, Xiaodong Huang, Shaoyan Liu, et al.
Oncotarget|February 10, 2017
Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinomaJunlin Yi, Xiaodong Huang, Zhengang Xu, et al.
Cancer Medicine|May 7, 2021
Stage-dependent conditional survival and failure hazard of non-metastatic nasopharyngeal carcinoma after intensity-modulated radiation therapy: Clinical implications for treatment strategies and surveillanceJingbo Wang, Xiaodong Huang, Shiran Sun, et al.
BMC Cancer|November 29, 2022
Induction TPF followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locally advanced hypopharyngeal cancer: a preliminary analysis of a randomized phase 2 trialXi Luo, Xiaodong Huang, Jingwei Luo, et al.
Journal of the National Cancer Center|July 22, 2024
Pretreatment systemic immune-inflammation index predicts survival for non-metastatic nasopharyngeal carcinoma: two independent institutional studiesFengge Zhou, Liting Liu, Xiaodong Huang, et al.
Frontiers in Oncology|August 28, 2020
Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy Does Not Improve Treatment Outcomes for Stage II Nasopharyngeal Carcinoma: A Phase 2 Multicenter Clinical TrialXiaodong Huang, Xiaozhong Chen, Chong Zhao, et al.
Pageof 5